Central Serous Chorioretinopathy

"Central Serous Chorioretinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.

Descriptor ID	D056833
MeSH Number(s)	C11.768.175
Concept/Terms	Central Serous Chorioretinopathy Central Serous Chorioretinopathy Central Serous Chorioretinopathies Chorioretinopathies, Central Serous Chorioretinopathy, Central Serous Serous Chorioretinopathies, Central Serous Chorioretinopathy, Central Central Serous Retinopathy Central Serous Retinopathies Retinopathies, Central Serous Retinopathy, Central Serous Serous Retinopathies, Central Serous Retinopathy, Central

Below are MeSH descriptors whose meaning is more general than "Central Serous Chorioretinopathy".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Central Serous Chorioretinopathy [C11.768.175]

Below are MeSH descriptors whose meaning is related to "Central Serous Chorioretinopathy".

Below are MeSH descriptors whose meaning is more specific than "Central Serous Chorioretinopathy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Central Serous Chorioretinopathy" by people in this website by year, and whether "Central Serous Chorioretinopathy" was a major or minor topic of these publications.

Bar chart showing 15 publications over 8 distinct years, with a maximum of 4 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	0	1
2015	4	0	4
2016	3	0	3
2017	1	0	1
2018	2	0	2
2020	1	0	1
2021	1	1	2
2022	1	0	1

Below are the most recent publications written about "Central Serous Chorioretinopathy" by people in Profiles.

Negretti GS, Kalafatis NE, Shields JA, Shields CL. Choroidal Melanoma Masquerading as Central Serous Chorioretinopathy. Ophthalmol Retina. 2023 02; 7(2):171-177.

View in: PubMed
Javle M, Roychowdhury S, Kelley RK, Sadeghi S, Macarulla T, Weiss KH, Waldschmidt DT, Goyal L, Borbath I, El-Khoueiry A, Borad MJ, Yong WP, Philip PA, Bitzer M, Tanasanvimon S, Li A, Pande A, Soifer HS, Shepherd SP, Moran S, Zhu AX, Bekaii-Saab TS, Abou-Alfa GK. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol Hepatol. 2021 10; 6(10):803-815.

View in: PubMed
Gopal AD, Meeker A, Ramesh S. Bilateral orbital granulomatosis with polyangiitis complicated by central serous chorioretinopathy. Clin Exp Optom. 2022 03; 105(2):233-236.

View in: PubMed
Iovino C, Au A, Chhablani J, Parameswarappa DC, Rasheed MA, Cennamo G, Cennamo G, Montorio D, Ho AC, Xu D, Querques G, Borrelli E, Sacconi R, Pichi F, Woodstock E, Sadda SR, Corradetti G, Boon CJF, van Dijk EHC, Loewenstein A, Zur D, Yoshimi S, Freund KB, Peiretti E, Sarraf D. Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study. Am J Ophthalmol. 2020 09; 217:104-113.

View in: PubMed
Rahimy E, Pitcher JD, Hsu J, Adam MK, Shahlaee A, Samara WA, Vander JF, Kaiser RS, Chiang A, Spirn MJ, Fineman MS. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR). Retina. 2018 May; 38(5):962-969.

View in: PubMed
Kanesa-Thasan A, Fawzi AA, Gill MK. PRESENTATION OF CENTRAL SEROUS CHORIORETINOPATHY IN TWO HUSBAND AND WIFE COUPLES. Retin Cases Brief Rep. 2018 Spring; 12(2):100-102.

View in: PubMed
Hunter DG, Yonekawa Y, Shah AS, Dagi LR. Central serous chorioretinopathy following medial transposition of split lateral rectus muscle for complete oculomotor nerve palsy. J AAPOS. 2017 12; 21(6):517-518.

View in: PubMed
Yonekawa Y, Thomas BJ, Capone A. Ultra-Wide-Field Autofluorescence in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Chorioretinopathy. JAMA Ophthalmol. 2016 Apr; 134(4):e155033.

View in: PubMed
Ghadiali Q, Jung JJ, Yu S, Patel SN, Yannuzzi LA. CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY. Retina. 2016 Mar; 36(3):611-8.

View in: PubMed
Dansingani KK, Balaratnasingam C, Freund KB, Klufas MA, Sarraf D. Reply. Am J Ophthalmol. 2016 Mar; 163:193-194.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement